Tbx5-dependent pathway regulating diastolic function in congenital heart disease

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Developmental Biology

Background:

• Cardiac myocyte relaxation is crucial for heart function.
• Impaired relaxation contributes significantly to heart failure.
• The complete regulatory pathways for cardiac relaxation are not fully understood.

Purpose of the Study:

• To investigate the role of T-box transcription factor 5 (Tbx5) in cardiac myocyte relaxation.
• To determine if Tbx5 haploinsufficiency causes cell-autonomous defects in ventricular relaxation.
• To elucidate the molecular mechanisms by which Tbx5 regulates cardiac diastolic function.

Main Methods:

• Utilized a mouse model of Tbx5 haploinsufficiency.
• Assessed cell-autonomous ventricular relaxation.
• Quantified sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2a (Atp2a2) expression and activity.
• Performed promoter activity assays for Atp2a2.
• Evaluated diastolic filling in Holt-Oram syndrome patients.

Main Results:

• Tbx5 haploinsufficiency in mice leads to cell-autonomous defects in ventricular relaxation.
• Tbx5 dosage modulates the expression of Atp2a2.
• Tbx5 directly activates the Atp2a2 promoter.
• Tbx5 haploinsufficiency results in impaired Ca2+ uptake dynamics and prolonged Ca2+ transients in ventricular myocytes.
• Holt-Oram syndrome patients exhibit significant diastolic filling abnormalities.

Conclusions:

• Tbx5 plays a direct role in regulating cardiac diastolic function.
• A genetic pathway involving Tbx5 and Atp2a2 is critical for cardiac relaxation.
• Patients with congenital heart defects associated with Tbx5 mutations may have underlying diastolic dysfunction that requires clinical attention.